Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Scribe Therapeutics is a clinical-stage developer of in vivo CRISPR-based genetic medicines with a compact market cap of roughly $397M and a platform-led upside profile. Technicals and short-interest dynamics make it a tradable long with asymmetric upside if upcoming platform and clinical catalysts validate delivery and efficacy. This idea lays out…
Options market pricing indicates Barclays Plc shares could swing about 4.3% when the bank releases third-quarter results on Oct. 22 before the market opens. Historical comparisons show the options-implied range has been exceeded on some recent reporting dates but not consistently, reflecting intermittent surprises around earnings.
Pinterest blends high-margin, asset-light economics with improving monetization and AI-driven content relevance. At roughly $12.3B market cap and $21.76 per share, the risk/reward tilts in favor of a tactical long on a mid-term horizon. This trade targets regained multiple expansion as engagement and ad yield pick up, while keeping a disciplined st…
Jazz Pharmaceuticals is shifting from a sleep-and-epilepsy story to a more diversified oncology + CNS commercial franchise. Positive OS data and a recent label expansion for Ziihera, plus the Actio acquisition and strong free cash flow, give the stock a catalyst-driven upside while valuation remains reasonable at ~14.5x earnings. This trade targets…
Arrowhead is being re‑priced by clinical momentum: a positive ARO-MAPT readout appears to validate CNS delivery and expands the addressable opportunity for its RNAi platform. The stock is trading on attractive technicals (RSI ~27) with elevated short interest, and the company still carries a large market cap of roughly $8.25B despite negative earni…
Zevra (ZVRA) combines a clean balance sheet and meaningful free cash flow with an FDA-approved rare-disease drug that appears conservatively priced versus market comparables. The stock trades at an enterprise value below what you'd expect for a company with positive cash flow, an approved product and a $150M voucher sale behind it. This trade targe…
Western Digital has the product mix and revenue momentum to be a clear AI infrastructure beneficiary, yet recent selling has pushed the stock to an attractive entry. We lay out an actionable trade with precise entry, stop and target, plus the catalysts and risks that will determine whether WDC re-rates toward a more normal growth multiple.
New Oriental’s pivot away from K-12 tutoring into adult education, test prep, and livestream commerce is producing real margin recovery and revenue growth. Recent operational beats, stronger guidance, and large institutional buys argue for a tactically long swing trade into a likely Q1 beat. Risk-managed entry at $57.50 with a $68 target balances u…
AeroVironment (AVAV) is trading near $120 with a market cap around $6.1B, a cheap P/S relative to its growth runway, and a record funded backlog. This trade idea takes a constructive long stance: enter on weakness, limit downside with a tight stop, and target a meaningful re-rating as contracts convert to revenue and margins recover.
Broadcom has engineered strong operational cash flow, but rising use of off-balance-sheet financing and payment arrangements creates a tail of refinancing and disclosure risk. This trade idea outlines a mid-term short that aims to capture a re-pricing event if credit markets tighten or disclosures trigger multiple compression.
Golar LNG is seeing tangible execution wins - new vessel conversion, multi-decade charters, and a growing EBITDA backlog - while the stock trades below clear upside to prior highs and conversion parity. We outline a mid-term trade plan that banks on continued project de-risking, short-covering potential, and multiple re-rating catalysts.
Centene (CNC) has re-rated sharply in 2026 as Medicaid margins improve and marketplace profitability recovers. Valuation metrics look reasonable against trailing losses and strong free cash flow. We lay out an actionable long trade: entry at $70.91, stop at $62.00 and a target of $85.00 with a primary horizon of 45 trading days and a secondary view…
Costamare is a containership owner with a growing contracted revenue profile from newbuilds and recent acquisitions. At $14.80 the stock trades at ~5.9x P/E and 0.84x P/B with a ~3.0% yield. We view this as a tactical long: enter at $14.80, stop $13.00, target $18.00 over a long-term (180 trading days) horizon, while monitoring charter renewals, de…
IRSA (IRS) is trading at a material discount to reported book value (PB 0.76), yields ~10.1% and carries a low PE of ~3.8. With a market cap of roughly $1.24B and a 52-week range of $11.17–$19.14, the risk/reward favors a long trade targeting mean reversion toward book and sentiment-driven rerating. This idea includes a clear entry at $13.80, stop …
Hut 8 has been sold off alongside other neocloud names despite meaningful long-duration contracts, a large market cap anchored by contracted capacity, and still-healthy liquidity metrics. The trade: initiate a long position on a tactical pullback that prices in some execution risk, use a tight stop to limit downside, and target a recovery toward gr…
Stronger-than-expected September headline and core US inflation readings pushed markets into a rapid reassessment of Federal Reserve policy, reviving concerns about a potential October rate hike and fueling a renewed selloff in AI-linked stocks. Data center builder CoreWeave and cloud giant Oracle saw steep drops in equity prices and dramatic widen…
Alibaba ($BABA) is investing aggressively in AI and data-center scale to turn Cloud into a trillion-RMB business. Revenue momentum in AI Cloud (AI product lines up triple-digits in recent quarters; AI Cloud grew ~45% YoY) plus a reasonable valuation (market cap $276.6B; P/E 24.6) underpin a long trade. Expect volatility while capex suppresses free …
Unit Corporation is executing aggressive G&A reductions that materially improve its free cash flow profile and make the path to shareholder returns clearer. We view the announcement as an inflection point that should drive a mid-term re-rating. Trade plan: enter $15.00, stop $12.50, target $21.00 (mid term - 45 trading days).
Tesla will unveil a redesigned Roadster at a SpaceX test site in McGregor, Texas, more than seven years after the company first showed a prototype. The vehicle, initially revealed in 2017 with a $200,000 price tag and $50,000 reservation requirement, has been delayed repeatedly; Tesla executives have downplayed its direct financial impact even as a…
Chewy is moving beyond e-commerce into higher-margin pet health and clinic services. With Q2 fiscal 2026 sales of $3.33B, autoship strength and triple-digit growth in Vet Care, the setup is a classic execution/re-rating trade. Enter near $20.85 with a $28 target and a $17.40 stop over a 180-trading-day horizon.
SentinelOne has moved from deep-value recovery to a clear beneficiary of the AI security narrative. With a $7.94B market cap, improving sentiment, and still-conservative fundamentals, I recommend a mid-term long trade sized for a disciplined risk budget. Entry $23.00, stop $19.00, target $30.00 (45 trading days).
Village Farms ($VFF) has pulled back from its recent highs but the setup favors a re-rate. Strong export momentum, improving margins and conservative leverage give the stock room to move higher. This is a mid-term swing trade with defined risk and a clear thesis: fundamentals justify a higher multiple, and a measured entry here offers asymmetric up…
WisdomTree (WETF) looks set to report a Q3 2026 that should show operating leverage from fee-based revenue and continued product momentum. We initiate a tactical long trade ahead of the release: entry $18.50, stop $16.00, target $23.00. Mid-term horizon (45 trading days) to capture post-earnings re-rating while keeping risk controlled.
Granite Construction (GVA) is generating meaningful free cash flow while trading at a sub-12x EV/EBITDA multiple and a near-10% FCF yield. The company carries elevated leverage and negative reported EPS, but operational cash generation and a supportive infrastructure backdrop make the stock a buy for a long-term trade. Entry $107.73, stop $95.00, t…
Centene ($CNC) has shown meaningful operational improvement across Medicaid and Marketplace lines, trades on attractive EV/EBITDA and cash-flow multiples, and has a near-term catalyst cadence (Q3 results, Gold Card rollout) that could re-rate the shares. Enter a mid-term swing to capture further margin normalization while keeping risk tight given p…
